Fund Holdings — Casdin Capital, LLC

Total Portfolio Value:
$1.10B
Total Bought:
$131.73M
Total Sold:
$194.66M
Net Transaction:
-$62.94M
Notable People:
Eli D Casdin, Lawrence Jude Canzoneri, Alexandria Fisk, Angelo Crupi, Steven Michael Giordano
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
GeneDx Holdings Corp.CL A(WGS)3,507,1643,507,1640$310.61M$323.75M29.48%+$13.13M
Biolife Solutions Inc8,707,1657,707,165-1,000,000$198.87M$166.01M15.12%-$32.86M
Revolution Medicines, Inc.(RVMD)3,697,9332,887,933-810,000$130.76M$106.25M9.68%-$24.51M
Standard BioTools Inc.(LAB)76,075,63676,075,6360$82.16M$91.29M8.31%+$9.13M
Illumina, Inc.(ILMN)595,000645,000+50,000$47.21M$61.54M5.60%+$14.33M
Avidity Biosciences Inc2,045,0001,775,000-270,000$60.37M$50.41M4.59%-$9.96M
Verve Therapeutics Inc3,995,5714,095,571+100,000$18.26M$45.99M4.19%+$27.73M
Relay Therapeutics, Inc.(RLAY)9,098,57411,398,574+2,300,000$23.84M$39.44M3.59%+$15.60M
Alnylam Pharmaceuticals, Inc.(ALNY)120,00081,500-38,500$32.40M$26.58M2.42%-$5.83M
Structure Therapeutics IncADS700,0001,225,000+525,000$12.12M$25.41M2.31%+$13.29M
Beam Therapeutics Inc.(BEAM)1,425,5621,450,000+24,438$27.84M$24.66M2.25%-$3.18M
Neurogene Inc.(NGNE)1,295,3611,295,3610$15.17M$19.37M1.76%+$4.20M
Codexis, Inc.(CDXS)8,100,0007,200,000-900,000$21.79M$17.57M1.60%-$4.22M
Sarepta Therapeutics, Inc.(SRPT)900,783990,097+89,314$57.49M$16.93M1.54%-$40.56M
Denali Therapeutics Inc.(DNLI)990,000890,000-100,000$13.46M$12.45M1.13%-$1.01M
Hims & Hers Health, Inc.CL A(HIMS)200,000230,000+30,000$5.91M$11.47M1.04%+$5.56M
Maze Therapeutics, Inc.(MAZE)946,357758,857-187,500$10.42M$9.31M0.85%-$1.11M
Veracyte, Inc.(VCYT)276,308276,3080$8.19M$7.47M0.68%-$723.9K
Eli Lilly and Company(LLY)08,500+8,500$0$6.63M0.60%+$6.63M
Syndax Pharmaceuticals, Inc.(SNDX)635,000650,000+15,000$7.80M$6.08M0.55%-$1.72M
Septerna, Inc.(SEPN)553,268553,2680$3.20M$5.85M0.53%+$2.64M
Guardant Health, Inc.(GH)250,000100,000-150,000$10.65M$5.20M0.47%-$5.45M
Endeavour Silver Corp.(EXK)405,00090,000-315,000$17.53M$4.78M0.44%-$12.75M
Prime Medicine, Inc.(PRME)367,1751,567,175+1,200,000$730.7K$3.87M0.35%+$3.14M
Agios Pharmaceuticals, Inc.(AGIO)250,000100,000-150,000$7.33M$3.33M0.30%-$4.00M
Absci Corporation973,260973,2600$2.44M$2.50M0.23%+$58.4K
Pacific Biosciences of California, Inc.(PACB)723,767723,7670$854.0K$897.5K0.08%+$43.4K
Recursion Pharmaceuticals, Inc.CL A(RXRX)165,323165,3230$874.6K$836.5K0.08%-$38.0K
Century Therapeutics, Inc.(IPSC)3,212,3161,228,190-1,984,126$1.53M$686.2K0.06%-$842.9K
Contineum Therapeutics, Inc.CL A(CTNM)148,333148,3330$1.04M$588.9K0.05%-$446.5K
Ginkgo Bioworks Holdings, Inc.CL A(DNA)36,49336,4930$208.0K$410.5K0.04%+$202.5K
Monte Rosa Therapeutics, Inc.(GLUE)86,01486,0140$399.1K$387.9K0.04%-$11.2K
Tenaya Therapeutics, Inc.(TNYA)6,732,971361,969-6,371,002$3.84M$221.2K0.02%-$3.62M
2seventy Bio Inc2,000,0000-2,000,000$9.88M$0—-$9.88M
BeOne Medicines AGADS(ONC)40,0000-40,000$10.89M$0—-$10.89M
Blueprint Medicines Corp326,3780-326,378$28.89M$0—-$28.89M
Dyne Therapeutics, Inc.(DYN)100,0000-100,000$1.05M$0—-$1.05M
GE HealthCare Technologies Inc.(GEHC)100,0000-100,000$8.07M$0—-$8.07M
Intellia Therapeutics, Inc.(NTLA)2,000,0000-2,000,000$14.22M$0—-$14.22M
Kronos Bio Inc123,8390-123,839$102.2K$0—-$102.2K
Moderna, Inc.(MRNA)225,0000-225,000$6.38M$0—-$6.38M
Solid Biosciences Inc775,0000-775,000$2.87M$0—-$2.87M
Tango Therapeutics, Inc.(TNGX)125,0000-125,000$171.3K$0—-$171.3K
Teladoc Health, Inc.(TDOC)300,0000-300,000$2.39M$0—-$2.39M
Verastem, Inc.(VSTM)600,0000-600,000$3.62M$0—-$3.62M
Page 1 of 1
Casdin Capital, LLC — 13F Holdings — Q2 2025 | TickerTrail